Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

2024 Updates on Carcinoid Heart Disease

North American Neuroendocrine Tumor Society

A. Nohria

Cardio-Oncology: Immune Checkpoint Inhibitor Associated Myocarditis

UCLA Health

E. Yang

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Total Health

I. Rhea

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

General Approach to Cardio-Oncology in Breast Cancer

Total Health

I. Rhea

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

ESC 2024 Insights: 2022 ESC Guidelines on Cardio-Oncology: What Do t…

ESC 2024 Insights

R. Asteggiano

Masonic Cancer Center Cardio-Oncology Updates

Masonic Cancer Center, University of Minnesota

S. Konety